Oliver Bisazza joined MedTech Europe in 2017, originally heading the department which supports members in implementing new and changing EU regulatory requirements affecting the medical technology industry.

In January 2023, Oliver assumed the role of Chief Executive Officer, responsible for the association’s overall management and strategy and reporting to the Board of Directors.

Oliver’s passion is to see the value of medical technology innovation fully recognised as a source of solutions to the many challenges facing healthcare systems, economies and societies, both in Europe and around the world.

Prior to joining MedTech Europe, he worked at Medtronic as Director of Regulatory Policy for EMEA.

As the Director of Digital Health at MedTech Europe since October 2022, Alexander Olbrechts oversees all activities related to digital regulations impacting the medical technology sector. The primary areas of focus include artificial intelligence, data management & governance, the European Health Data Space, and cyber resilience.

Before joining MedTech Europe, Alexander was employed by the Belgian technology association and actively participated in multiple other European associations. Throughout his professional career, he has consistently demonstrated a strong commitment to advancing digital health.

Patrick Boisseau joined MedTech Europe in 2020 as Director EU Research & Innovation Partnership Policies. He develops, promotes, represents and leads the industry in EU Research and Innovation Partnerships or Programmes, working on European projects and interacting with the European Commission in the set-up, follow-up and coordination of European funding(ed) projects and any other similar EU initiatives. Patrick leads MedTech Europe activities and representation in critical framework programmes such as Horizon Europe, EIT Health and others.

In his capacity as Director General, he leads the development of key Industry Strategic Initiatives. Patrick drives the three following key strategic initiatives: MedTech Europe Value-Based Health Care deployment, Digital Health expansion and finalising the EU/Medtech industry public-private partnership to support research and innovation in the healthcare industry.

Hubert Gambs has been Deputy Director-General at the Directorate for Internal Market, Industry, Entrepreneurship and SMEs (DG GROW) since July 2020.

He was previously Director for Modernisation of the Single Market in DG GROW (2016- 2020), Director for Mediterranean and Black Sea in DG MARE (2014-2016), Head of Cabinet of Johannes Hahn, Commissioner for Regional Policy (2010-2014), Member of Cabinet of Commissioner Ferrero-Waldner (2004-2010) and Commissioner Fischler (2004).

From 1998 to 2004 he worked as a case handler in DG COMP and administrator in the General Secretariat of the Council of the EU (1996-1998). Before joining the EU institutions, he worked as a case handler at the Federal Ministry of Economic Affairs in Vienna.

He studied Law at the University of Innsbruck.

Saila Rinne is the Head of Sector for policy in the unit “eHealth, Well-Being and Ageing” at the Directorate-General for Communications Networks, Content and Technology (DG CONNECT) of the European Commission. Her team deals with policies and projects that foster secure access to health data and promote innovative tools, services and products for the benefit of efficient health and care delivery and citizens’ empowerment in managing their own health. She has had a long career at the Commission and has previously worked on data policy and innovation projects in DG CONNECT and as a translator and terminologist in DG Translation.

Marc holds an MSc from the Ecole des Mines de Nancy and an MBA from INSEAD. During his 30 years of working experience, he worked as a strategic consultant or investor in major leading companies (LEK Consulting, Schneider Electric …) and institutions (FSI – BPI France) and he launched and led several start-ups including for the last 6 years Diabeloop. He also held board positions in over 10 companies and trade associations. 

Over the last 6 years, he led, Diabeloop, a medtech company whose mission is to make technological innovations available to all families living with type 1 diabetes that was granted for several projects by EIT Health. The projects D4Kids and D4Teens enhanced and adapted an advanced artificial pancreas, the Diabeloop DBLG1 System, to the needs of children with Type 1 diabetes. In 2019, Marc Julien won the EIT Award recognising the most promising entrepreneurs and innovators in Europe and Nasdaq Healthtech of the year. 

In January 2023, Marc Julien became Transition Managing Director of EIT Health France and was selected to be the Managing Director of EIT Health France on the 1^st of July 2023. 

Marc will help drive the evolution of EIT Health in France focusing on reinforcing the French Partnership, pushing toward more sustainability, and developing EIT Health position in the French ecosystem.

Christian Clarus is Director Global Government Affairs and responsible for political communication at B. Braun, one of the world’s leading providers and manufacturers of healthcare solutions today. As a political scientist, he is experienced in political decision-making and policy-making processes on national and international levels. With more than 15 years in the sector, his large network includes elected officials, lawmakers, industry associations and other relevant institutions. Amongst other engagements, Christian serves as Chair of the Public Affairs Committee and as Vice-Chair of the International Affairs Committee at MedTech Europe. He also represents B. Braun at the Atlantic-Briicke, a non-profit association in service of German-American Friendship.

Flora Giorgio is a trained pharmacist and joined the European Commission in 2006 to work in DG Information Society and Media (now DG CNECT) as policy and project officer in the ICT for Health Unit.

She joined DG SANTE in 2012 and since 2015 she has been heading the Health Technology Assessment team responsible for the drafting and the successful negotiating for the Regulation on Health technology Assessment. From July 2021, Flora has been first Deputy Head of Unit, then since March 2023 Acting Head of Unit Head and since 16 July appointed Head of Unit of Unit of Unit D3 “Medical Devices”.

Before joining the European Commission, Flora has been working in community pharmacy and she has been Secretary General of the Pharmaceutical Group of the European Union representing community pharmacists.